Endoscopic subureteric collagen injection (SCIN): a new alternative treatment of vesicoureteric reflux in children

Abstract

Endoscopic subureteric injection has become an accepted form of treatment for vesicoureteric reflux in children in selected cases. However, the commonly injected substance Teflon has raised doubts as to its long-term safety. Glutaraldehyde cross-linked bovine collagen, which is not associated with the feared side effects of Teflon (granuloma formation, particle migration), seems to be an adequate replacement. At the Departement of Paediatric Surgery of the Basel University Children's Hospital 54 patients with a total of 82 refluxing units were treated with the subureteric collagen injection (SCIN) in the period between June 88 and August 90; 45 patients were female and 9 were male. The average age at treatment was 4.9 years (2 months– 15.2 years). Micturating cystourethrograms performed 3 months after injection showed disapperance of reflux in 61.3% (49 ureters).If improvement to grade I and II reflux was included, the success rate increased to 77.5%. After two SCIN procedures 77.6% of the ureters became free of reflux. Including improvement to grade I and II reflux, the success rate increased to 83.8%. The mean follow-up time was 11.5 months (2–27 months). Injection-related complications were not observed. Although the overall results were not as good as those after surgical correction of reflux and the long-term effects of the collagen implants are not yet known, SCIN seems to be a simple alternative treatment for vesicoureteric reflux in children.